Comparison results
| Results: Differences General | ✘D72.1 | ✘E59 | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 10% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| basophilia | 9% | — | ||||||||||
| arsenic poisoning | — | 42% | ||||||||||
| increased ESR | 7% | — | ||||||||||
| lowered | — | 38% | ||||||||||
| neutrophilosis | 7% | — | ||||||||||
| barley | — | 37% | ||||||||||
| hematocrit is reduced | 7% | — | ||||||||||
| liver problems | — | 36% | ||||||||||
| lymphocytosis | 7% | — | ||||||||||
| violation of accommodation | — | 35% | ||||||||||
| stick neutrophils increased | 7% | — | ||||||||||
| lot of things | — | 34% | ||||||||||
| neutropenia | 6% | — | ||||||||||
| blepharitis | — | 32% | ||||||||||
| hypersthenuria | 6% | — | ||||||||||
| impotence | — | 32% | ||||||||||
| leukocytosis | 6% | — | ||||||||||
| increased | 4% | 35% | ||||||||||
| with reactive protein increased | 6% | — | ||||||||||
| cut wound | — | 30% | ||||||||||
| protein with increased | 5% | — | ||||||||||
| reduced efficiency | — | 29% | ||||||||||
| for an increase in ige | 5% | — | ||||||||||
| mental exhaustion | — | 28% | ||||||||||
| lymphopenia | 5% | — | ||||||||||
| dysbacteriosis | — | 28% | ||||||||||
| mchc reduced | 5% | — | ||||||||||
| pyoderma | — | 28% | ||||||||||
| increased alt | 4% | — | ||||||||||
| intoxication | — | 28% | ||||||||||
| piebaldism | 4% | — | ||||||||||
| emotional burnout | — | 28% | ||||||||||
| anemia | 3% | — | ||||||||||
| emotional exhaustion | — | 27% | ||||||||||
| albinism | 3% | — | ||||||||||
| mental tension | — | 27% | ||||||||||
| chediak-higashi syndrome | 3% | — | ||||||||||
| purulent rashes on the skin | — | 27% | ||||||||||
| fever weakness | 2% | — | ||||||||||
| emotional tension | — | 26% | ||||||||||
| photophobia | 2% | — | ||||||||||
| high intelligence | — | 26% | ||||||||||
| neuroses in children | 2% | — | ||||||||||
| toxic liver | — | 25% | ||||||||||
| hepatosplenomegaly | 2% | — | ||||||||||
| severe exhaustion | — | 25% | ||||||||||
| intellectual disabilities in children | 2% | — | ||||||||||
| decreased intelligence | — | 25% | ||||||||||
| enlargement of the spleen | 2% | — | ||||||||||
| rash pustules | — | 25% | ||||||||||
| sensitive child | 2% | — | ||||||||||
| liver failure | — | 24% | ||||||||||
| enlargement of the liver and spleen | 2% | — | ||||||||||
| wounds heal poorly | — | 24% | ||||||||||
| smart baby | 2% | — | ||||||||||
| impaired function of the small intestine | — | 24% | ||||||||||
| epilepsy in children | 2% | — | ||||||||||
| no strength | — | 24% | ||||||||||
| purulent lymphadenitis | 2% | — | ||||||||||
| weakening of immunity | — | 24% | ||||||||||
| primary immunodeficiency | 2% | — | ||||||||||
| scratch | — | 23% | ||||||||||
| tendency to bleed | 2% | — | ||||||||||
| frequent colds | — | 23% | ||||||||||
| eosinophilia | 2% | — | ||||||||||
| suppuration of the skin | 1% | 23% | ||||||||||
| lymphadenitis in children | 2% | — | ||||||||||
| intestinal insufficiency syndrome | — | 22% | ||||||||||
| hemophagocytic syndrome | 2% | — | ||||||||||
| rapid weight loss | — | 22% | ||||||||||
| pancytopenia | 2% | — | ||||||||||
| overwork | — | 22% | ||||||||||
| takes methotrexate | 2% | — | ||||||||||
| visual impairment | — | 22% | ||||||||||
| hemorrhagic fevers | 2% | — | ||||||||||
| loss body weight | — | 22% | ||||||||||
| neurological disorders | 2% | — | ||||||||||
| nose nursing mom | — | 22% | ||||||||||
| convulsive syndrome in children | 2% | — | ||||||||||
| consequences of injuries | — | 21% | ||||||||||
| exhaustion | — | 21% | ||||||||||
| immunodeficiency | 2% | 22% | ||||||||||
| wound | — | 20% | ||||||||||
| emotional | — | 20% | ||||||||||
| cancer | — | 20% | ||||||||||
| impaired lung function | — | 20% | ||||||||||
| enlarged liver | 4% | 23% | ||||||||||
| trauma | — | 19% | ||||||||||
| periodic illness | — | 19% | ||||||||||
| diseases of the gastrointestinal tract | — | 19% | ||||||||||
| skin problems | 1% | 19% | ||||||||||
| childhood diseases | 1% | 19% | ||||||||||
| inflammation | — | 18% | ||||||||||
| oncology | 1% | 18% | ||||||||||
Instructions
Video
|